| CAMZYOS MyoKardia, Inc.
97539194 08 Aug 2022 | on 03 Sep 2024
| Pharmaceutical preparations for prevention and treatment of cardiovasc... Class 005 Class 005 Pharmaceutical Products The mark consists of the word "CAMZYOS" in stylized, solid font except for the "O", which is variegated and lighter in shade than the other letters. | | | MY CAMZYOS PATIENT SUPPORT MyoKardia, Inc.
97110494 05 Nov 2021 | on 05 Dec 2023
| Health care services, namely, providing information to physicians, hea... Class 044 Class 044 Medical, Beauty & Agricultural Services "PATIENT SUPPORT" | | | CAMZYOS MyoKardia, Inc.
88693134 14 Nov 2019 | on 02 Aug 2022
| pharmaceutical preparations for prevention and treatment of cardiovasc... Class 005 Class 005 Pharmaceutical Products pharmaceutical preparations for prevention and treatment of cardiovascular diseases and disorders | | | MYOKARDIA MyoKardia, Inc.
88592645 26 Aug 2019 | on 12 Jan 2021
| Providing funding and research grants to academic institutions and fou... Class 005 Class 005 Pharmaceutical Products Providing funding and research grants to academic institutions and foundations for researchers and clinicians for supporting original research in the field of medical research Class 036 Class 036 Insurance & Financial Services The mark consists of a heart design, with four lines crossing the heart, to the left of the word "MYOKARDIA", with "MYO" in bold font. Class 044 Medical, Beauty & Agricultural Services Color is not claimed as a feature of the mark. | | | MYOKARDIA MyoKardia, Inc.
88283756 31 Jan 2019 | on 08 Sep 2020
| Pharmaceutical preparations for prevention and treatment of cardiovasc... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for prevention and treatment of cardiovascular diseases and disorders Class 036 Class 036 Insurance & Financial Services MYOCARDIA Class 044 Medical, Beauty & Agricultural Services Providing funding and research grants to researchers and clinicians for supporting original research | | | DRIVEN BY THE HEART MyoKardia, Inc.
88599920 30 Aug 2019 | on 07 Apr 2020
| Providing funding and research grants to researchers and clinicians fo... Class 036 Class 036 Insurance & Financial Services Providing funding and research grants to researchers and clinicians for supporting research in the field of medical research Class 044 Class 044 Medical, Beauty & Agricultural Services Providing funding and research grants to researchers and clinicians for supporting research in the field of medical research | | | CAMZYOS MyoKardia, Inc.
98478203 01 Apr 2024 | on 03 Dec 2024 | Health care services, namely, providing information to physicians, hea... Class 044 Class 044 Medical, Beauty & Agricultural Services The mark consists of the word CAMZYOS in stylized, solid font except for the "O", which is variegated and lighter in shade than the other letters. | | | PAKZYOS MyoKardia, Inc.
90702301 11 May 2021 | on 23 Oct 2024 | Pharmaceutical preparations for human use for the treatment and preven... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; monoclonal antibodies | | | PAZNYOS MyoKardia, Inc.
90702305 11 May 2021 | on 23 Oct 2024 | Pharmaceutical preparations for human use for the treatment and preven... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; monoclonal antibodies | | | QZIO MyoKardia, Inc.
90702307 11 May 2021 | on 15 Oct 2024 | Pharmaceutical preparations for human use for the treatment and preven... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; monoclonal antibodies | | 
